Allergan Inc. (AGN) reported that its fourth-quarter net earnings attributable to stockholders were $221.5 million or $0.72 per share, compared to $146.6 million or $0.48 per share in the year ago quarter.
Non-GAAP net earnings attributable to stockholders were $238.1 million or $0.78 per share, compared to $229.8 million or $0.76 per share last year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.77 per share for the quarter. Analysts' estimates typically exclude special items.
Revenues for the quarter were $1.22 billion, compared to $1.06 billion in the prior year quarter. Sixteen analysts had consensus revenue estimate of $1.16 billion for the quarter.
Allergan also announced that its Board of Directors has declared a fourth quarter dividend of $0.05 per share, payable on March 12, 2010 to stockholders of record on February 19, 2010.
For the first quarter of 2010, Allergan expects total product net sales between $1.060 billion and $1.100 billion. Non-GAAP earnings per share attributable to stockholders are expected to be between $0.57 and $0.59. Analysts expect the company to report earnings of $0.68 per share for the quarter.
For the full year of 2010, Allergan expects total product net sales to be between $4.550 billion and $4.750 billion. Non-GAAP earnings per share attributable to stockholders are expected to be between $3.09 and $3.15. Analysts expect the company to report earnings of $3.15 per share for fiscal 2010.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.